Description:
Home Page: www.pfizer.com
0Q1N Technical Analysis
235 East 42nd Street
New York,
NY
10017
United States
Phone:
212 733 2323
Officers
| Name | Title |
|---|---|
| Dr. Albert Bourla D.V.M., DVM, Ph.D. | Chairman & CEO |
| Mr. Frank A. D'Amelio | CFO & Exec. VP |
| Dr. Mikael Dolsten M.D., Ph.D. | Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical |
| Mr. Douglas M. Lankler | Exec. VP & Gen. Counsel |
| Mr. John D. Young | Advisor |
| Ms. Angela Hwang | Chief Commercial Officer & Pres of Global Biopharmaceuticals Bus. |
| Mr. David M. Denton | Chief Financial Officer & Exec. VP |
| Ms. Jennifer B. Damico | Sr. VP, Controller & Principal Accounting Officer |
| Ms. Lidia L. Fonseca | Exec. VP and Chief Digital & Technology Officer |
| Mr. Christopher J. Stevo CFA | Sr. VP & Chief Investor Relations Officer |
Exchange: LSE
Country: GB
Currency: US Dollar ($)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Commercial & Professional Services |
| GIC Industry: | Commercial Services & Supplies |
| GIC Sub-Industry: | Environmental & Facilities Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 83000 |